Phase I/II Trial of rBPI-21 (a Recombinant 21kD Fragment of Bactericidal/Permeability-Increasing Protein) in Children with Severe Meningococcemia. † 196 | Zendy

AI Assistant Blog Pricing

Phase I/II Trial of rBPI-21 (a Recombinant 21kD Fragment of Bactericidal/Permeability-Increasing Protein) in Children with Severe Meningococcemia. † 196

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.